Three bases for distinguishing bone cancer from benign bone tumors

The incidence of benign bone tumors is higher than that of bone cancer, and the impact and harm on patients are also less severe, with a good prognosis. The treatment methods of the two are also quite different, so special attention should be paid to the differential diagnosis of the two to avoid unnecessary damage. The key points for distinguishing bone cancer from benign bone tumors are mainly the following three aspects:

1. Systemic reaction

Patients with acute inflammation will have elevated body temperature and increased white blood cell count, while patients with benign bone tumors will have normal body temperature and blood counts. However, patients with bone cancer often have elevated body temperature and increased white blood cell counts. In addition, patients with bone cancer often show increased erythrocyte sedimentation rate, while patients with benign bone tumors have normal erythrocyte sedimentation rate.

2. Development process

As the disease progresses, the tumor in bone cancer patients gradually grows larger and the damage to surrounding tissues becomes more and more serious. It rarely improves or disappears on its own. However, when benign bone tumors develop to a certain extent, they will usually stop on their own and alleviate the damage to surrounding tissues.

3. Local palpation

The tumors of bone cancer patients are very hard and have a solid feel when touched. The boundaries are very clear. Due to adhesions, the tumors are relatively fixed and often have no obvious sense of fluctuation. Only a small number of early bone cancers with very rich blood vessels may have obvious fluctuations. The tumors of benign bone tumors feel very soft when touched and often have a more obvious sense of fluctuation.